Synthesis

Characterisation
The structures of intermediates and products were confirmed by 1 H NMR and 1 H-1 H correlation spectroscopy (Varian Gemini 300 HC instrument), deuteriochloroform was used as a solvent and the signals of the solvent served as an internal standard, J values being given in Hz. The elemental analyses were carried out on a Perkin-Elmer 2400 instrument. The purity of all final compounds was confirmed by HPLC analysis (Luna Silica 150×4.5 column) and found >99.8%. Column chromatography was carried out using Merck Kieselgel 60 (60-100 m).
Experimental
Materials of series I (E)-4-((4-Hexadecyloxyphenyl)diazenyl)phenyl 3-(tert-butyl(dimethyl)silyloxy)-4-methylbenzoate (7)
. A solution of acid 1 (150 mg, 0.56 mmol), phenol 5 (260 mg, 0.59 mmol), DCC (120 mg, 0.58 mmol) and a catalytic amount of DMAP (25 mg, 0.20 mmol) in dry dichloromethane (25 ml) was stirred for 24 h at room temperature in an inert atmosphere of argon. The precipitated dicyclohexylurea was filtered off and washed with dichloromethane (5 ml). The filtrate was evaporated and the crude product purified by column chromatography (toluene/tert-butyl methyl ether, 20/1) yielding 270 mg (71%) of 7 as an orange solid, m.p. 98-99°C. 1 
4-(4-Hexadecyloxybenzoyl)oxyphenyl 3-benzyloxy-4-methylbenzoate (8).
A mixture of acid 2 (260 mg, 0.84 mmol), phenol 5 (400 mg, 0.88 mmol), DCC (180 mg, 0.88 mmol) and a catalytic amount of DMAP (50 mg, 0.41 mmol) in dry dichloromethane (50 ml) was stirred for 24 h at room temperature in an inert atmosphere of argon. The precipitated dicyclohexylurea was filtered off and washed with dichloromethane (5 ml). The filtrate was evaporated and the crude product purified by crystallization from an ethyl acetate/ethanol mixture. It was obtained 270 mg (71%) of 8 as a white solid, m.p. 117-118°C. 1 (E)-4-((4-Hexadecyloxyphenyl)diazenyl)phenyl 3-hydroxy-4-methylbenzoate (9). To a solution of 7 (200 mg, 0.29 mmol) in aqueous 90% tetrahydrofuran (22 ml), TBAF·3 H 2 O (23 mg, 0.07 mmol) was added and the reaction mixture was stirred for 1 h at room temperature. The reaction was poured into water (50 ml) and the resulting suspension was extracted with ethyl acetate (225 ml). The combined organic solution was washed with water and dried with anhydrous magnesium sulphate. The solvent was evaporated and the crude product was purified by column chromatography (toluene/isobutyl methyl ketone) yielding 160 mg (82%) of a yellow solid, m.p. 170-172 °C. 1 4-(4-Hexadecyloxybenzoyloxy)phenyl 3-hydroxy-4-methylbenzoate (10). To a hot solution of benzyl derivative 8 (420 mg, 0.62 mmol) and Pd/C (50 mg, 10% w/w) in dry 2-pentanone (20 ml), ammonium formate (120 mg, 1.90 mmol) was added and the reaction mixture was stirred under reflux in an inert argon atmosphere for 3 h. The reaction mixture was filtered while hot. The filtrate was evaporated and the crude product was purified by column chromatography (toluene/ isobutyl methyl ketone) yielding 230 mg (64%) of a white solid, m.p. 140-142 °C. 1 
4-[3-(4-(4-Hexadecyloxybenzoyloxy)benzoyloxy)-4-methylbenzoyloxy]phenyl 4-hexadecyloxybenzoate (Ia).
From a boiling solution of 10 (100 mg, 0.17 mmol) and DMAP (22 mg, 0.18 mmol) in toluene (20 ml), approximately 3 ml of the solvent were distilled off in order to remove traces of water. The heating bath was removed and to the still hot solution, a solution of acid chloride 12 (90 mg, 0.18 mmol) in dry toluene (5 ml) was added at once via syringe. The reaction mixture was stirred under inert argon atmosphere and left to cool down to room temperature. Then it was poured into 2% aqueous hydrochloric acid (30 ml) and the resulting suspension was extracted with chloroform (3  30 ml). The combined organic solution was washed with water (15 ml), brine (10 ml) and dried with anhydrous magnesium sulphate. The solvent was evaporated, and the crude product purified by column chromatography (toluene/tert-butyl methyl ether) providing 140 mg (78%) of Ia. The target material was further purified by multiple crystallisation from an ethyl acetate/ethanol mixture. 1 Using the same synthetic pathway as for series I, the materials of series II were prepared. 
4-(4-Hexadecyloxybenzoyloxy)phenyl (E)-3-[(4-(4-hexadecyloxyphenyl)diazenyl)benzoyloxy]-4-methylbenzoate (Ic
Materials of series II (E)-4-((4-Hexadecyloxyphenyl)diazenyl)phenyl 3-(tert-butyl(dimethyl)silyloxy)-6-methylbenzoate (13). Similarly as for
4-(4-
Hexadecyloxybenzoyloxy
Mesomorphic behaviour
For compound Ib, x-ray measurements confirmed the tilted SmC s phase for all smectic mesophases, no other organization in layers has been found. Details of textures observed under polarizing microscope are presented. For compound Ib only small textural details allow us to distinguish between different smectic SmC s mesophases (Fig. S1 ). In 
Photochemical properties
In the following figures, the thermal relaxation of UV-irradiation-induced Z-isomer back to more stable E-isomer is depicted. 
4.
Ab initio calculations All calculations were performed in Gaussian 03W ® , initial geometries were designed and results visualized in GaussView 3.0 ® . The optimization procedure followed the same procedure, we previously described for laterally substituted 3-hydroxybenzoic acid-based bent-core liquid crystals. 1 In brief, the geometry of side wings 6 and 12 as well as intermediate 16 was adopted from reference 1 and re-calculated with the method used in this publication. Since azobenzenebased side arm is a planar fragment, E-isomer of which is much more stable than corresponding Z-isomer, planar alignment in E-configuration of the azo bond was the only considered arrangement. Additionally, it has already been described that the carbonyl unit connected to the aromatic ring lies in the same plane as the corresponding aromatic unit. 2 Therefore, for the intermediate 9, only the orientation of connecting ester unit was considered ( Figure S5) . Similarly, different conformations of the side wing 11 have not been considered and only the orientation of the ester linkage was studied in the final material IIc.
